SECTION N3/PR0JECT 1/ALIVISATOS PI: Gambhir, Sanjiv S N3.1.1. Project Summary: The long-term goal of PI is to engineer, synthesize, characterize and optimize the next generation nanoparticle platforms that can potentially be translated clinically to develop nanodiagnostics and imaging agents for in vitro and in vivo use for the improved management of cancer. The role of PI in the overall scheme of this CCNE-T application is shown in Fig. N3.1.1, Our primary focus for this CCNE application is to develop and use nanotechnology for monitoring response to anti-cancer therapy and for earlier cancer detectior . Our cancer focus in the current proposal is on both lung and ovarian cancers but expect that our strategies will eventually apply to many cancers. Both in vitro nanosensors and in vivo nanomolecular imaging will be utilized to accomplish our long-term goals. The combination of both In vitro and In vivo diagnostic strategies is expected to lead to a much greater accuracy and cost-effectiveness than either strategy alone. To translate our in vitro and in vivo diagnostic strategies we will utilize mouse models that help us to test our approaches prior to clinical translation. The clinical translation will be accomplished through the clinical translation core (Core 3) which links to various clinical trials and leverages on other funding mechanisms already in place in our CCNE. In order to meet the improved nanoparticle needs of our other proposed Research Projects, PI will be focusing on the development of these newer types of nanoparticles and nano-strategies as described in sections below. We envision that these new types of nanoparticles will have outstanding advantages for biomedical imaging and the development of in vitro diagnostics such as for multimodal imaging, multiplexing, multi-effector functionalities, improved signal amplification via outstanding signal to noise ratio characteristics of the to-be-developed nanocrystals. These advantages are especially valuable with clinical biological fluid samples which always present significant challenges. Thus, the focus of P1 will be the realization of the next generation nanoparticles, their in vitro , characterization in cell culture models, and the delivery of these nanoparticles to the other projects for further detailed studies to assess cancer iviodeis&their utility as cancer diagnostics and cancer imaging agents. This project also fulfills the requirement of the CCNE RFA wherein a basic research project with nanotechnology discovery was listed as one of the required projects. Being a fundamental nanoscience Figure N3.1.1. The thematic discovery project, the proposed P1 meets this condition. The PI consists areas ofthe projects and of two Discovery Nanotechnology sub-projects, as described below

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA151459-05
Application #
8726312
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
5
Fiscal Year
2014
Total Cost
$973,458
Indirect Cost
$746,215
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Shah, Preyas N; Lin, Tiras Y; Aanei, Ioana L et al. (2018) Extravasation of Brownian Spheroidal Nanoparticles through Vascular Pores. Biophys J 115:1103-1115
Song, Guosheng; Chen, Min; Zhang, Yanrong et al. (2018) Janus Iron Oxides @ Semiconducting Polymer Nanoparticle Tracer for Cell Tracking by Magnetic Particle Imaging. Nano Lett 18:182-189
Lee, Jung-Rok; Appelmann, Iris; Miething, Cornelius et al. (2018) Longitudinal Multiplexed Measurement of Quantitative Proteomic Signatures in Mouse Lymphoma Models Using Magneto-Nanosensors. Theranostics 8:1389-1398
Vermesh, Ophir; Aalipour, Amin; Ge, T Jessie et al. (2018) An intravascular magnetic wire for the high-throughput retrieval of circulating tumour cells in vivo. Nat Biomed Eng 2:696-705
Li, Jingchao; Rao, Jianghong; Pu, Kanyi (2018) Recent progress on semiconducting polymer nanoparticles for molecular imaging and cancer phototherapy. Biomaterials 155:217-235
Pohling, Christoph; Campbell, Jos L; Larson, Timothy A et al. (2018) Smart-Dust-Nanorice for Enhancement of Endogenous Raman Signal, Contrast in Photoacoustic Imaging, and T2-Shortening in Magnetic Resonance Imaging. Small 14:e1703683
Rizzi, Giovanni; Lee, Jung-Rok; Dahl, Christina et al. (2017) Simultaneous Profiling of DNA Mutation and Methylation by Melting Analysis Using Magnetoresistive Biosensor Array. ACS Nano 11:8864-8870
Mohanty, Suchismita; Chen, Zixin; Li, Kai et al. (2017) A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. Mol Cancer Ther 16:1909-1921
Kani, Kian; Garri, Carolina; Tiemann, Katrin et al. (2017) JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines. Mol Cancer Ther 16:1645-1657
Lee, Jung-Rok; Chan, Carmel T; Ruderman, Daniel et al. (2017) Longitudinal Monitoring of Antibody Responses against Tumor Cells Using Magneto-nanosensors with a Nanoliter of Blood. Nano Lett 17:6644-6652

Showing the most recent 10 out of 143 publications